A detailed history of Northern Oak Wealth Management Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Northern Oak Wealth Management Inc holds 10,041 shares of ABBV stock, worth $1.81 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares
10,041
Previous 18,554 45.88%
Holding current value
$1.81 Million
Previous $3.18 Million 37.71%
% of portfolio
0.23%
Previous 0.38%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

SELL
$163.84 - $199.33 $1.39 Million - $1.7 Million
-8,513 Reduced 45.88%
10,041 $1.98 Million
Q2 2024

Jul 26, 2024

SELL
$154.79 - $180.76 $5.25 Million - $6.13 Million
-33,920 Reduced 64.64%
18,554 $3.18 Million
Q1 2024

May 01, 2024

SELL
$159.82 - $182.1 $4.11 Million - $4.68 Million
-25,702 Reduced 32.88%
52,474 $9.56 Million
Q4 2023

Jan 11, 2024

SELL
$137.6 - $154.97 $1.28 Million - $1.44 Million
-9,299 Reduced 10.63%
78,176 $12.1 Million
Q3 2023

Oct 24, 2023

BUY
$133.59 - $154.65 $304,050 - $351,983
2,276 Added 2.67%
87,475 $13 Million
Q2 2023

Jul 31, 2023

BUY
$132.51 - $164.9 $5.51 Million - $6.85 Million
41,546 Added 95.17%
85,199 $11.5 Million
Q1 2023

May 09, 2023

BUY
$144.61 - $166.54 $3.93 Million - $4.53 Million
27,204 Added 165.38%
43,653 $6.96 Million
Q4 2022

Feb 13, 2023

SELL
$138.31 - $165.87 $145,917 - $174,992
-1,055 Reduced 6.03%
16,449 $2.66 Million
Q3 2022

Nov 14, 2022

BUY
$134.21 - $153.93 $723,928 - $830,298
5,394 Added 44.54%
17,504 $2.35 Million
Q2 2022

Aug 16, 2022

SELL
$137.62 - $174.96 $670,209 - $852,055
-4,870 Reduced 28.68%
12,110 $1.86 Million
Q1 2022

May 24, 2022

SELL
$131.98 - $163.75 $10.5 Million - $13 Million
-79,590 Reduced 82.42%
16,980 $2.75 Million
Q4 2021

Feb 16, 2022

BUY
$107.43 - $135.93 $307,572 - $389,167
2,863 Added 3.06%
96,570 $13.1 Million
Q3 2021

Nov 15, 2021

BUY
$106.4 - $120.78 $452,306 - $513,435
4,251 Added 4.75%
93,707 $10.1 Million
Q2 2021

Aug 17, 2021

BUY
$105.21 - $117.21 $394,958 - $440,006
3,754 Added 4.38%
89,456 $10.1 Million
Q1 2021

May 14, 2021

BUY
$102.3 - $112.62 $648,172 - $713,560
6,336 Added 7.98%
85,702 $9.28 Million
Q4 2020

Feb 16, 2021

BUY
$80.49 - $108.67 $561,659 - $758,299
6,978 Added 9.64%
79,366 $8.5 Million
Q3 2020

Nov 16, 2020

BUY
$85.91 - $100.83 $295,530 - $346,855
3,440 Added 4.99%
72,388 $6.34 Million
Q2 2020

Aug 17, 2020

BUY
$73.37 - $98.18 $467,000 - $624,915
6,365 Added 10.17%
68,948 $6.77 Million
Q1 2020

May 15, 2020

BUY
$64.5 - $97.79 $3.73 Million - $5.65 Million
57,798 Added 1207.9%
62,583 $4.77 Million
Q4 2019

Jan 27, 2020

SELL
$72.13 - $90.25 $20,196 - $25,270
-280 Reduced 5.53%
4,785 $423,000
Q3 2019

Oct 31, 2019

SELL
$62.98 - $75.72 $102,972 - $123,802
-1,635 Reduced 24.4%
5,065 $383,000
Q2 2019

Jul 30, 2019

SELL
$65.7 - $83.98 $51,048 - $65,252
-777 Reduced 10.39%
6,700 $0
Q1 2019

Apr 24, 2019

BUY
$77.14 - $90.79 $7,482 - $8,806
97 Added 1.31%
7,477 $0
Q4 2018

Feb 14, 2019

SELL
$77.85 - $96.01 $38,224 - $47,140
-491 Reduced 6.24%
7,380 $680,000
Q3 2018

Nov 15, 2018

SELL
$88.91 - $98.84 $6.12 Million - $6.81 Million
-68,875 Reduced 89.74%
7,871 $0
Q2 2018

Aug 13, 2018

BUY
$89.78 - $106.23 $3.84 Million - $4.54 Million
42,752 Added 125.76%
76,746 $0
Q1 2018

May 11, 2018

SELL
$92.01 - $123.21 $7.07 Million - $9.46 Million
-76,796 Reduced 69.32%
33,994 $0
Q4 2017

Feb 16, 2018

SELL
$89.56 - $98.21 $9.92 Million - $10.9 Million
-110,730 Closed
0 $0
Q3 2017

Nov 15, 2017

BUY
$69.85 - $89.22 $7.73 Million - $9.88 Million
110,730
110,730 $0

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Northern Oak Wealth Management Inc Portfolio

Follow Northern Oak Wealth Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Oak Wealth Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Northern Oak Wealth Management Inc with notifications on news.